SRC and cancer: examined lung adenocarcinoma and lung endothelial cells in vitro and demonstrated that lidocaine not only inhibited TNFα-induced Src activation in both cell types, but also reduced cancer cell migration and endothelial cell permeability, as well as neutrophil adhesion (121, 122).